Commonwealth Equity Services, LLC Iterum Therapeutics PLC Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022
SELL
$0.39 - $0.74 $8,580 - $16,280
-22,000 Closed
0 $0
Q3 2021

Oct 29, 2021
BUY
$0.54 - $2.29 $5,562 - $23,587
10,300 Added 88.03%
22,000 $12,000
Q2 2021

Aug 11, 2021
SELL
$0.97 - $2.39 $6,596 - $16,252
-6,800 Reduced 36.76%
11,700 $27,000
Q1 2021

May 04, 2021
BUY
$0.97 - $2.73 $17,945 - $50,505
18,500 New
18,500 $26,000

Others Institutions Holding ITRM

# of Institutions
3
Shares Held
145
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $19M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email